Abstract:BackgroundThe global spread of bacterial resistance has given rise to a growing interest in new anti-bacterial agents with a new strategy of action. Pilicides are derivatives of ring-fused 2-pyridones which block the formation of the pili/fimbriae crucial to bacterial pathogenesis. They impair by means of a chaperone-usher pathway conserved in the Gram-negative bacteria of adhesive structures biogenesis. Pili/fimbriae of this type belong to two subfamilies, FGS and FGL, which differ in the details of their ass… Show more
“…16,27–29 — express a large, highly conserved family of adhesive fibres called chaperone–usher pathway (CUP) pili 25,26 . CUP pili are assembled by the chaperone–usher molecular machinery 24,25 and are composed of pilin subunits with incomplete immunoglobulin-like folds that lack the typical carboxy-terminal seventh β-strand 30,31 . Briefly, in a process termed donor-strand complementation, a dedicated periplasmic chaperone ‘donates’ a β-strand to complete the immunoglobulin fold of the subunits, forming a complex with each subunit and ensuring their proper folding and stabilization.…”
Section: Adherence and Colonizationmentioning
confidence: 99%
“…Targeting CUP pilus function or assembly has therapeutic potential, as it should block UPEC colonization, invasion and biofilm formation, thus preventing disease 30,31,120,121 .…”
Section: Treatment Of Urinary Tract Infectionsmentioning
confidence: 99%
“…They have a 2-pyridone scaffold 28,30,31,120 and function by selectively targeting and interfering with crucial chaperone–usher interactions. Further studies have been carried out to investigate their broad spectrum of activity against other CUP pili 122 .…”
Section: Treatment Of Urinary Tract Infectionsmentioning
confidence: 99%
“…Thus, the potency of pilicide ec240 is largely due to its ability to induce a phase OFF orientation of the type 1 pilus promoter, rather than any interference with chaperone–usher interactions. Additional work revealed that other pilicides also inhibit the production of Dr pili, another type of UPEC CUP pili that are known to be important in pyelonephritis in mice and humans 30,33 . Furthermore, pilicides have been shown to disrupt CUP pilus biogenesis in K. pneumoniae and also in Haemophilus influenzae (a finding that has important implications for otitis media) 24,29 .…”
Section: Treatment Of Urinary Tract Infectionsmentioning
Urinary tract infections (UTIs) are a severe public health problem and are caused by a range of pathogens, but most commonly by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterococcus faecalis and Staphylococcus saprophyticus. High recurrence rates and increasing antimicrobial resistance among uropathogens threaten to greatly increase the economic burden of these infections. In this Review, we discuss how basic science studies are elucidating the molecular details of the crosstalk that occurs at the host–pathogen interface, as well as the consequences of these interactions for the pathophysiology of UTIs. We also describe current efforts to translate this knowledge into new clinical treatments for UTIs.
“…16,27–29 — express a large, highly conserved family of adhesive fibres called chaperone–usher pathway (CUP) pili 25,26 . CUP pili are assembled by the chaperone–usher molecular machinery 24,25 and are composed of pilin subunits with incomplete immunoglobulin-like folds that lack the typical carboxy-terminal seventh β-strand 30,31 . Briefly, in a process termed donor-strand complementation, a dedicated periplasmic chaperone ‘donates’ a β-strand to complete the immunoglobulin fold of the subunits, forming a complex with each subunit and ensuring their proper folding and stabilization.…”
Section: Adherence and Colonizationmentioning
confidence: 99%
“…Targeting CUP pilus function or assembly has therapeutic potential, as it should block UPEC colonization, invasion and biofilm formation, thus preventing disease 30,31,120,121 .…”
Section: Treatment Of Urinary Tract Infectionsmentioning
confidence: 99%
“…They have a 2-pyridone scaffold 28,30,31,120 and function by selectively targeting and interfering with crucial chaperone–usher interactions. Further studies have been carried out to investigate their broad spectrum of activity against other CUP pili 122 .…”
Section: Treatment Of Urinary Tract Infectionsmentioning
confidence: 99%
“…Thus, the potency of pilicide ec240 is largely due to its ability to induce a phase OFF orientation of the type 1 pilus promoter, rather than any interference with chaperone–usher interactions. Additional work revealed that other pilicides also inhibit the production of Dr pili, another type of UPEC CUP pili that are known to be important in pyelonephritis in mice and humans 30,33 . Furthermore, pilicides have been shown to disrupt CUP pilus biogenesis in K. pneumoniae and also in Haemophilus influenzae (a finding that has important implications for otitis media) 24,29 .…”
Section: Treatment Of Urinary Tract Infectionsmentioning
Urinary tract infections (UTIs) are a severe public health problem and are caused by a range of pathogens, but most commonly by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterococcus faecalis and Staphylococcus saprophyticus. High recurrence rates and increasing antimicrobial resistance among uropathogens threaten to greatly increase the economic burden of these infections. In this Review, we discuss how basic science studies are elucidating the molecular details of the crosstalk that occurs at the host–pathogen interface, as well as the consequences of these interactions for the pathophysiology of UTIs. We also describe current efforts to translate this knowledge into new clinical treatments for UTIs.
“…Thus, the potency of pilicide 2 is in part due to the unexpected mechanism of inducing a phase OFF orientation of the type 1 pilus promoter. Additionally, pilicide activity against Dr pili, another type of CUP pili known to play a role in pyelonephritis in mice and humans, has also been confirmed, further expanding the therapeutic potential of these compounds in targeting UTI (154). The exciting ability of these compounds to target multiple CUP pili suggests that these compounds could demonstrate broad therapeutic coverage in the clinic.…”
Section: Small-molecule Inhibitors Of Cup Pili Biogenesismentioning
Bacterial adherence to host tissue is an essential process in pathogenesis, necessary for invasion and colonization and often required for the efficient delivery of toxins and other bacterial effectors. As existing treatment options for common bacterial infections dwindle, we find ourselves rapidly approaching a tipping point in our confrontation with antibiotic-resistant strains and in desperate need of new treatment options. Bacterial strains defective in adherence are typically avirulent and unable to cause infection in animal models. The importance of this initial binding event in the pathogenic cascade highlights its potential as a novel therapeutic target. This article seeks to highlight a variety of strategies being employed to treat and prevent infection by targeting the mechanisms of bacterial adhesion. Advancements in this area include the development of novel antivirulence therapies using small molecules, vaccines, and peptides to target a variety of bacterial infections. These therapies target bacterial adhesion through a number of mechanisms, including inhibition of pathogen receptor biogenesis, competition-based strategies with receptor and adhesin analogs, and the inhibition of binding through neutralizing antibodies. While this article is not an exhaustive description of every advancement in the field, we hope it will highlight several promising examples of the therapeutic potential of antiadhesive strategies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.